Alfresa Holdings Corporation (TYO:2784)
2,273.50
+23.00 (1.02%)
Nov 12, 2025, 3:30 PM JST
Alfresa Holdings Revenue
Alfresa Holdings had revenue of 771.64B JPY in the quarter ending September 30, 2025, with 5.13% growth. This brings the company's revenue in the last twelve months to 3.03T, up 5.11% year-over-year. In the fiscal year ending March 31, 2025, Alfresa Holdings had annual revenue of 2.96T with 3.59% growth.
Revenue (ttm)
3.03T
Revenue Growth
+5.11%
P/S Ratio
0.14
Revenue / Employee
243.69M
Employees
12,452
Market Cap
413.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.96T | 102.55B | 3.59% |
| Mar 31, 2024 | 2.86T | 162.43B | 6.02% |
| Mar 31, 2023 | 2.70T | 110.43B | 4.27% |
| Mar 31, 2022 | 2.59T | -17.53B | -0.67% |
| Mar 31, 2021 | 2.60T | -95.34B | -3.53% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.04T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |